Week In Review: Innovent's Hong Kong IPO: Raising $422 Million At $2 Billion Valuation
October 20, 2018 at 17:16 PM EDT
Innovent Biologics of Suzhou plans to raise $422 million in its Hong Kong IPO at a $2 billion valuation, according to multiple media reports. The company, formed in 2011, struck a major $1 billion collaboration with Lilly in 2015.
